Yu‐Chi Chou

1.4k total citations
55 papers, 851 citations indexed

About

Yu‐Chi Chou is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Yu‐Chi Chou has authored 55 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 20 papers in Infectious Diseases and 11 papers in Epidemiology. Recurrent topics in Yu‐Chi Chou's work include SARS-CoV-2 and COVID-19 Research (16 papers), Hepatitis B Virus Studies (9 papers) and COVID-19 Clinical Research Studies (7 papers). Yu‐Chi Chou is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (16 papers), Hepatitis B Virus Studies (9 papers) and COVID-19 Clinical Research Studies (7 papers). Yu‐Chi Chou collaborates with scholars based in Taiwan, United Kingdom and United States. Yu‐Chi Chou's co-authors include Chung-Ming Chang, Mong-Liang Chen, King-Song Jeng, Cheng-po Hu, Ruey‐Hwa Chen, Ya-Ling Chen, Ming-Yang Wang, Hsin‐Yi Chen, Yi‐Ching Wang and Boon Shing Tan and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Molecular Cell.

In The Last Decade

Yu‐Chi Chou

54 papers receiving 841 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Chi Chou Taiwan 18 339 272 187 162 121 55 851
Ximeng Han China 14 340 1.0× 100 0.4× 229 1.2× 173 1.1× 64 0.5× 24 909
Shi Liu China 17 323 1.0× 351 1.3× 134 0.7× 93 0.6× 104 0.9× 35 791
Nanfang Peng China 15 296 0.9× 205 0.8× 132 0.7× 68 0.4× 108 0.9× 15 651
Guangyun Tan China 17 331 1.0× 356 1.3× 184 1.0× 272 1.7× 99 0.8× 30 962
Olivier Diaz France 18 335 1.0× 596 2.2× 118 0.6× 405 2.5× 141 1.2× 30 1.2k
Shiou-Hwei Yeh Taiwan 13 258 0.8× 495 1.8× 306 1.6× 449 2.8× 53 0.4× 19 1.1k
Ian Gaël Rodrigue‐Gervais Canada 11 571 1.7× 199 0.7× 91 0.5× 137 0.8× 86 0.7× 13 880
Yonghong Zhu China 23 838 2.5× 221 0.8× 262 1.4× 188 1.2× 119 1.0× 43 1.5k
Yinong Duan China 17 229 0.7× 177 0.7× 65 0.3× 230 1.4× 109 0.9× 52 748

Countries citing papers authored by Yu‐Chi Chou

Since Specialization
Citations

This map shows the geographic impact of Yu‐Chi Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Chi Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Chi Chou more than expected).

Fields of papers citing papers by Yu‐Chi Chou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Chi Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Chi Chou. The network helps show where Yu‐Chi Chou may publish in the future.

Co-authorship network of co-authors of Yu‐Chi Chou

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Chi Chou. A scholar is included among the top collaborators of Yu‐Chi Chou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Chi Chou. Yu‐Chi Chou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chao, Tai‐Ling, Yongsen Ruan, Ya‐Wen Cheng, et al.. (2025). Tradeoffs between proliferation and transmission in virus evolution– insights from evolutionary and functional analyses of SARS-CoV-2. Virology Journal. 22(1). 107–107. 2 indexed citations
2.
Chen, Xiaorui, Lisa Schimanski, Tiong Kit Tan, et al.. (2024). The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccine. PLoS Pathogens. 20(6). e1012246–e1012246. 2 indexed citations
3.
Chou, Yu‐Chi, et al.. (2023). Core clock gene BMAL1 and RNA-binding protein MEX3A collaboratively regulate Lgr5 expression in intestinal crypt cells. Scientific Reports. 13(1). 17597–17597. 4 indexed citations
4.
Su, Wen‐Chi, King-Song Jeng, Yu‐Chi Chou, et al.. (2023). Functional assessments of SARS-CoV-2 single-round infectious particles with variant-specific spike proteins on infectivity, drug sensitivity, and antibody neutralization. Antiviral Research. 220. 105744–105744. 4 indexed citations
5.
Huang, Kuan-Ying A., Xiaorui Chen, Lisa Schimanski, et al.. (2023). Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2. Nature Communications. 14(1). 311–311. 26 indexed citations
6.
Lu, Ruei‐Min, Kang-Hao Liang, Hsiao-Ling Chiang, et al.. (2023). Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice. Heliyon. 9(5). e15587–e15587. 4 indexed citations
7.
Wang, Yi‐Hsuan, Kuen‐Phon Wu, Jean‐Cheng Kuo, et al.. (2023). PAICS ubiquitination recruits UBAP2 to trigger phase separation for purinosome assembly. Molecular Cell. 83(22). 4123–4140.e12. 19 indexed citations
8.
Chiang, Hsiu‐Mei, Yeh Chen, Chung‐Yu Chen, et al.. (2022). Prospects of Coffee Leaf against SARS-CoV-2 Infection. International Journal of Biological Sciences. 18(12). 4677–4689. 13 indexed citations
9.
Lien, Chia-En, Tsun‐Yung Kuo, Yi‐Jiun Lin, et al.. (2021). Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern. Clinical Infectious Diseases. 74(11). 1899–1905. 11 indexed citations
10.
Lee, Ying, Shiu-Lok Hu, Jia‐Tsrong Jan, et al.. (2021). Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters. PLoS ONE. 16(9). e0257191–e0257191. 16 indexed citations
11.
Murugaiah, Valarmathy, Yu‐Chi Chou, Hui-Fang Kao, et al.. (2021). Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles. Frontiers in Immunology. 12. 641360–641360. 45 indexed citations
12.
Liang, Kang-Hao, Shih-Han Ko, Yu‐Chi Chou, et al.. (2021). Antibody cocktail effective against variants of SARS-CoV-2. Journal of Biomedical Science. 28(1). 80–80. 17 indexed citations
14.
Liou, Gunn‐Guang, Chao‐Hsiung Lin, Mong-Liang Chen, et al.. (2015). The Inhibitory Effect of the Hepatitis B Virus Singly-Spliced RNA-Encoded p21.5 Protein on HBV Nucleocapsid Formation. PLoS ONE. 10(3). e0119625–e0119625. 17 indexed citations
15.
Yeong, Eng‐Kean, et al.. (2013). Effects of LED Light Irradiation on Human Foreskin Fibroblasts and Its Implication to Wound Healing. Journal of Medical and Biological Engineering. 33(2). 155–162. 2 indexed citations
16.
Yeh, Chau‐Ting, Cheng-po Hu, Ya-Ling Chen, et al.. (2013). One single nucleotide difference alters the differential expression of spliced RNAs between HBV genotypes A and D. Virus Research. 174(1-2). 18–26. 23 indexed citations
17.
Chou, Yu‐Chi, et al.. (2012). Transforming Growth Factor-β1 Suppresses Hepatitis B Virus Replication by the Reduction of Hepatocyte Nuclear Factor-4α Expression. PLoS ONE. 7(1). e30360–e30360. 44 indexed citations
18.
Chen, Mong-Liang, et al.. (2011). Dynamics of HBV cccDNA expression and transcription in different cell growth phase. Journal of Biomedical Science. 18(1). 96–96. 27 indexed citations
19.
Sun, Yu, et al.. (2008). Expression of recombinant anticoagulant hirudin in the differentiated cultures of the porcine mammary epithelial cell line SI‐PMEC. Cell Biology International. 32(7). 739–747. 5 indexed citations
20.
Chou, Yu‐Chi & Jim C. Fong. (1994). Enhanced cyclic AMP response in GH3 pituitary cells pretreated with muscarinic receptor agonists. Cellular Signalling. 6(4). 413–421. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026